Some antibiotics result in more multi-resistant and pathogenic E.coli

February 10, 2024

There is a clear correlation between the use of a particular type of antibiotic and the increased prevalence of a multi-resistant E. coli clone. Professor Jukka Corander and his colleagues have made an important breakthrough in our understanding of how the use of antibiotics can result in more dangerous and more resistant bacteria. Photo: Mona Mehus, University of OsloAfter analysing 5,000 E. coli infections in Norway and Great Britain during the period 2001-2017, the results leave us in no doubt. In 2005, scientists showed for the very first time that the use of various antibiotics coincided with the occurrence of serious bacterial infections that were resistant to the same antibiotics. Recommends national surveillance systemsThe study shows how important national surveillance systems are for combatting antibiotic resistance.

There is a clear correlation between the use of a particular type of antibiotic and the increased prevalence of a multi-resistant E. coli clone. This study illustrates the need for national surveillance systems to monitor antibiotic resistance.

Professor Jukka Corander and his colleagues have made an important breakthrough in our understanding of how the use of antibiotics can result in more dangerous and more resistant bacteria. Photo: Mona Mehus, University of Oslo

After analysing 5,000 E. coli infections in Norway and Great Britain during the period 2001-2017, the results leave us in no doubt.

In 2005, scientists showed for the very first time that the use of various antibiotics coincided with the occurrence of serious bacterial infections that were resistant to the same antibiotics. The report incorporated data from 26 European countries over a six-year period and attracted a lot of attention because it presented the hypothesis that use of antibiotics drives an increased prevalence of antibiotic-resistant bacteria in the population.

– Now, for the first time, we have been able to verify this hypothesis for one type of antibiotics often used to combat E. coli infections, explains professor Jukka Corander, who led the new study.

New and better technology

Technological developments, combined with data from two world-leading, national surveillance systems that monitor resistance in microbes, have provided scientists at the University of Oslo, UiT the Arctic University of Norway, the University of Cambridge and the Sanger Institute in Cambridge with the opportunity to carry out big-data analyses in order to investigate the causal relationship between the use of antibiotics and the occurrence of antibiotic resistance.

This time, the researchers generated to parallel sets of data derived from cases of blood poisoning with E. coli bacteria occurring over almost two decades: one set from England during the period 2001-2017 and one from Norway from 2002-2017.

– By comparing the results of the DNA analyses with the frequency of antibiotic use in the two countries, we were able for the first time to determine which types of antibiotics are particularly important for the growth of certain E. coli strains that are resistant to antibiotics.

Greater occurrence of infections in England

With the help of extensive data simulations, the scientists were able to investigate how different levels of the use of cephalosporin are related to how prevalent a bacterial strain is in the population.

– Our conclusion is that a more intensive use of the antibiotic cephalosporin in England than in Norway has resulted in a higher occurrence of infections caused by the multi-resistant E. coli strain ST131-C2 in British society.

Recommends national surveillance systems

The study shows how important national surveillance systems are for combatting antibiotic resistance. With the help of analyses of representative data drawn from a number of years, it is possible to draw clear conclusions about which factors have a bearing on the development of antibiotic resistance.

Collaboration of scientists from many countries

Scientists contributing to the study included researchers from the University of Oslo, UiT the Arctic University of Norway; Turku University Hospital Finland, Ninewells Hospital and Medical School in Scotland, the University Hospital of North Norway, Imperial College London, the University of Birmingham and the University of Cambridge.

How the study was funded

The research was funded by the Norwegian Trond Mohn Foundation via the AMR BATTALION project, Marie Sklodowska-Curie Actions and the European Research Council (ERC). The genome sequencing was carried out at the Wellcome Sanger Institute in Great Britain.

Contact information

Professor Jukka Corander

Scientific references from 2023 and 2005

Β-Lactam Antibiotic Use Modulates Multi-Drug Resistant Clone Success in Escherichia Coli Populations: A Longitudinal Multi-Country Genomic Cohort Study

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

The source of this news is from University of Oslo

Popular in Research

1

Feb 15, 2024

Fifth cohort of Hansen Scholars join the University of Melbourne

2

Feb 5, 2024

New Prostate Cancer Report Card keeps treatment options simple to understand

3

Feb 5, 2024

Innovative urban living concept tackles housing woes and offers socially connected solutions

4

Feb 6, 2024

New study aims to ease chronic pain for people with Parkinson’s

5

Feb 7, 2024

Effort to cure corneal blindness globally welcomes $35 million support

Roundup of Key Statements

Oct 14, 2023

New path facilitates campus access for students

Feb 2, 2023